User profiles for Naresh Sachdeva

Naresh Sachdeva

Professor (Immunology), Dept Endocrinology, PGIMER, Chandigarh, India
Verified email at pgimer.edu.in
Cited by 5595

Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)

…, V Suri, N Yaddanapudi, N Sachdeva… - Postgraduate …, 2022 - academic.oup.com
Background Vitamin D has an immunomodulatory role but the effect of therapeutic vitamin D
supplementation in SARS-CoV-2 infection is not known. Aim Effect of high dose, oral …

Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study

…, P Dutta, JS Thakur, N Sachdeva… - The Journal of …, 2010 - academic.oup.com
Context: Although glycated hemoglobin (HbA1c) has recently been incorporated as a diagnostic
test by the American Diabetes Association, its validity needs to be established in Asian …

Efficacy of autologous bone marrow–derived stem cell transplantation in patients with type 2 diabetes mellitus

…, N Marwaha, V Gupta, N Sachdeva… - Stem cells and …, 2009 - liebertpub.com
Progressive and inexorable β-cell dysfunction is the hallmark of type 2 diabetes mellitus (T2DM)
and β-cell regeneration using stem cell therapy may prove to be an effective modality. A …

Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida

…, K Deeb, M Diamante, M Ashman, N Sachdeva… - Immunobiology, 2014 - Elsevier
Background Analysis of peripheral blood lymphocyte subsets has become an essential tool
in the evaluation of outcome of diagnostic and research related questions in immunological …

Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: a randomized placebo-controlled study

…, S Bhansali, V Gupta, A Jain, N Sachdeva… - Cell …, 2014 - journals.sagepub.com
There is a growing interest in cell-based therapies in T2DM as β-cell failure is progressive
and inexorable with the advancing duration of disease. This prospective, randomized, single-…

Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey

…, S Bhansali, P Dutta, JS Thakur, N Sachdeva… - Diabetes research and …, 2010 - Elsevier
AIM: To determine the prevalence of and risk factors for metabolic syndrome (MS) among
urban Asian Indian adults. METHODS: 2225 subjects aged ≥20 years were studied in a …

Insulin resistance and metabolic syndrome in young men with acne

…, D De, S Handa, A Pal, N Sachdeva - JAMA dermatology, 2016 - jamanetwork.com
Introduction Robust evidence of the association of insulin resistance and metabolic syndrome
with acne in male patients is lacking. Objective To assess the prevalence of metabolic …

Efficacy of autologous bone marrow-derived mesenchymal stem cell and mononuclear cell transplantation in type 2 diabetes mellitus: a randomized, placebo …

…, N Khandelwal, A Srinivasan, N Sachdeva… - Stem cells and …, 2017 - liebertpub.com
Drugs targeting β-cells have provided new options in the management of T2DM; however,
their role in β-cell regeneration remains elusive. The recent emergence of cell-based …

Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF‐1 axis

…, D Bansal, R Walia, N Sachdeva… - Pediatric blood & …, 2013 - Wiley Online Library
Background The frontline treatment for chronic myeloid leukemia (CML) is tyrosine kinase
inhibitor therapy. There is increasing evidence that imatinib results in growth failure in children…

[HTML][HTML] Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene

G Sachdeva, S Gainder, V Suri… - Indian journal of …, 2019 - journals.lww.com
Objective: To compare the different polycystic ovarian syndrome (PCOS) phenotypes based
on their clinical, metabolic, hormonal profile, and their differential response to clomiphene. …